Watanabe, S.; Nishijima, N.; Hirai, K.; Shibata, K.; Hase, A.; Yamanaka, T.; Inazu, M.
Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells. Pharmaceuticals 2020, 13, 104.
https://doi.org/10.3390/ph13050104
AMA Style
Watanabe S, Nishijima N, Hirai K, Shibata K, Hase A, Yamanaka T, Inazu M.
Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells. Pharmaceuticals. 2020; 13(5):104.
https://doi.org/10.3390/ph13050104
Chicago/Turabian Style
Watanabe, Saiichiro, Nozomi Nishijima, Kaho Hirai, Kaoru Shibata, Akane Hase, Tsuyoshi Yamanaka, and Masato Inazu.
2020. "Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells" Pharmaceuticals 13, no. 5: 104.
https://doi.org/10.3390/ph13050104
APA Style
Watanabe, S., Nishijima, N., Hirai, K., Shibata, K., Hase, A., Yamanaka, T., & Inazu, M.
(2020). Anticancer Activity of Amb4269951, a Choline Transporter-Like Protein 1 Inhibitor, in Human Glioma Cells. Pharmaceuticals, 13(5), 104.
https://doi.org/10.3390/ph13050104